News

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers ...
A new single-cell RNA analysis method, STAMP, significantly reduces costs and biases, allowing for comprehensive profiling of ...
An international study published today in the New England Journal of Medicine sheds light on acute normovolemic hemodilution, ...
CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing attention as a next-generation gene therapy platform due to its precision and reduced side effects.